section name header

Table 66-3

World Health Organization (WHO) Classification of Myelodysplastic Syndromes (MDS)/Neoplasms

NAMERING SIDEROBLASTSMYELOBLASTSKARYOTYPE
MDS with single lineage dysplasia (MDS-SLD)<15% (<5%)aBM <5%, PB <1%, no Auer rodsAny, unless fulfills all criteria for MDS with isolated del(5q)
MDS with multilineage dysplasia (MDS-MLD)<15% (<5%)aBM <5%, PB <1%, no Auer rodsAny, unless fulfills all criteria for MDS with isolated del(5q)
MDS with ring sideroblasts (MDS-RS)
MDS-RS with single lineage dysplasia (MDS-RS-SLD)15% / 5%aBM <5%, PB <1%, no Auer rodsAny, unless fulfills all criteria for MDS with isolated del(5q)
MDS-RS with multilineage dysplasia (MDS-RS-MLD)15% / 5%aBM <5%, PB <1%, no Auer rodsAny, unless fulfills all criteria for MDS with isolated del(5q)
MDS with isolated del(5q)None or anyBM <5%, PB <1%, no Auer rodsdel(5q) alone or with 1 additional abnormality except -7 or del (7q)
MDS with excess blasts (MDS-EB)
MDS-EB-1None or anyBM 5-9% or PB 2-4%, no Auer rodsAny
MDS-EB-2None or anyBM 10-19% or PB 5-19% or Auer rodsAny

MDS, unclassifiable (MDS-U)

• with 1% blood blasts

• with single lineage dysplasia and pancytopenia

• based on defining cytogenetic abnormality

None or any

None or any

15%

BM <5%, PB=1%, no Auer rods

BM <5%, PB=1%, no Auer rods

BM <5%, PB=1%, no Auer rods

Any

Any

MDS-defining abnormality

MDS, unclassifiable (MDS-U)

• with 1% blood blasts

• with single lineage dysplasia and pancytopenia

• based on defining cytogenetic abnormality

None or any

None or any

15%

BM <5%, PB=1%, no Auer rods

BM <5%, PB=1%, no Auer rods

BM <5%, PB=1%, no Auer rods

Any

Any

MDS-defining abnormality

Refractory cytopenia of childhoodNoneBM <5%, PB <2%Any

a If SF3B1 mutation is present.

Abbreviations: BM, bone marrow; PB, peripheral blood.